back to Meetings page
  • IMMPACT-X
  • June 3-4, 2009
  • Ritz Carlton Pentagon City
  • Arlington, Virginia

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia and Related Participants
  • Edgar H. Adams, ScD (Covance)
  • John Brownstein, PhD (Harvard Medical School)
  • Sandra D. Comer, PhD (Columbia University)
  • Richard Dart, MD, PhD (Denver Health Hospital)
  • Nabarun Dasgupta, MPH (University of North Carolina)
  • Nathaniel P. Katz, MD (Analgesic Research and Tufts University)
  • Deborah B. Leiderman, MD (CNS Drug Consulting)
  • John D. Markman, MD (University of Rochester)
  • Edward Michna, MD, JD (Brigham and Women’s Hospital)
  • Alec B. O'Connor, MD (University of Rochester)
  • Sarah Peirce-Sandner, MS (University of Rochester)
  • Srinivasa N. Raja, MD (Johns Hopkins University)
  • Jennifer Sharpe-Potter, PhD (University of Texas Health Science Center)
  • Lynn R. Webster, MD (LifeTree Clinical Research and Pain Clinic)
  • Roger D. Weiss, MD (Harvard Medical School)
  • James P. Zacny, PhD (University of Chicago)
  • Government Participants
  • Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
  • Amina Chaudhry, MD (Substance Abuse and Mental Health Services Administration)
  • Richard A. Denisco, MD (National Institute of Health/NIDA)
  • Petra Jacobs, PhD (National Institute of Health/NIDA)
  • Michael Klein, PhD (US Food and Drug Administration)
  • Richard Lubran, MS, MPA (Substance Abuse and Mental Health Services Administration)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • Christine A. Sannerud, PhD (Drug Enforcement Administration)
  • Srihari R. Tella, PhD (Drug Enforcement Administration)
  • Patient Representatives
  • Penney Cowan (American Chronic Pain Association)
  • Kerry Wolf (NAMA-Recovery)
  • Industry Participants
  • Harry Ahdieh, PhD (Endo Pharmaceuticals)
  • Richard Malamut, PhD (AstraZeneca Pharmaceuticals)
  • Pamela Palmer, MD (AcelRx)
  • Christine Rauschkolb, MD, PhD (Johnson & Johnson)
  • Carl Roland, PhD (King Pharmaceuticals)